Advanced Therapeutics Pharmaceutical Outsourcing Market Expansion Is Reshaping Competitive Dynamics Across The Industry
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Advanced Therapeutics Pharmaceutical Outsourcing Market Forecast: What Market Value Is Expected By 2030?
The market for outsourced advanced therapeutic pharmaceuticals has experienced consistent expansion over recent years. Valued at $8.41 billion in 2025, it is projected to increase to $8.82 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.0%. This upward trajectory in the historical period is driven by several factors, including a growing pipeline of biologics, the substantial expenses associated with internal manufacturing, a rising incidence of oncology and rare diseases, a shortage of specialized internal knowledge regarding advanced therapies, and the worldwide spread of clinical trial activities.
The market for advanced therapeutics pharmaceutical outsourcing is anticipated to experience substantial expansion over the coming years, reaching a value of $10.73 billion by 2030 at a compound annual growth rate (CAGR) of 5.0%. This projected growth is driven by several factors, including the increasing adoption of personalized medicine, the commercial-scale rollout of cell and gene therapies, heightened regulatory complexities, a surge in funding for biotech startups, and an urgent need for shorter development timelines. Key developments shaping this period involve the growing trend of outsourcing manufacturing for cell and gene therapies, a rising preference for comprehensive contract development and manufacturing organization (CDMO) services, expansion in specialized viral vector production capabilities, an intensified emphasis on regulatory and quality compliance assistance, and accelerated clinical trial outsourcing for rare and complex disease indications.
Download A Free Sample Report For Comprehensive Market Insights:
Advanced Therapeutics Pharmaceutical Outsourcing Market Growth Momentum: Which Factors Are Influencing Demand?
The growing utilization of cell and gene therapies is anticipated to accelerate progress in the advanced therapeutics pharmaceutical outsourcing market moving forward. These therapies represent innovative approaches that employ living cells or genetic components to address and potentially cure various medical conditions. Outsourcing within advanced therapeutics for pharmaceuticals facilitates connection to vendors possessing proven capabilities and skilled teams, allowing organizations to free up time and resources that would otherwise be spent on assembling their own workforce. As an illustration, in March 2024, data from IQVIA Holdings Inc., a US entity specializing in sophisticated analytics, technology solutions, and clinical research services for life sciences and healthcare, revealed that worldwide expenditure on cell and gene therapies reached $5.9 billion in 2023, marking a 38% rise compared to 2022. Consequently, the heightened uptake of cell and gene therapies is fueling expansion in the market for advanced therapeutics pharmaceutical outsourcing.
Advanced Therapeutics Pharmaceutical Outsourcing Market Segment Outlook: Which Categories Are Expanding The Fastest?
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented –
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services
Advanced Therapeutics Pharmaceutical Outsourcing Market Trends Reshaping Industry Growth
Within the advanced therapeutics pharmaceutical outsourcing market, major companies are increasingly prioritizing strategic partnerships as a key approach to delivering dependable services to their customers. A strategic partnership represents a collaborative framework involving two or more organizations, typically businesses, that is designed to pursue mutually beneficial objectives unattainable by any single entity acting alone. A notable example occurred in January 2023, when Lonza, a Swiss-based manufacturer serving the pharmaceutical, biotechnology, and nutrition sectors, entered into an alliance with Context Therapeutics Inc., a US-based biopharmaceutical company focused on advancing treatments for solid tumors. This collaboration sees Lonza taking on responsibilities such as conducting manufacturability assessments, developing gene and cell line constructs, and managing process development for both the drug substance and the drug product.
Advanced Therapeutics Pharmaceutical Outsourcing Market Key Companies And Competitive Benchmarking
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, AGC Biologics, Evotec SE, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cytovance Biologics
Access The Complete Advanced Therapeutics Pharmaceutical Outsourcing Market Report:
Advanced Therapeutics Pharmaceutical Outsourcing Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2025. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
